Quick Answer
Atea Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $1.94 (loss) per share for the year ending 2025.
- Atea Pharmaceuticals, Inc. showed an increase of +3.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Atea Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $0.40 (loss) per share | Q2 2020: $0.99 (loss) per share | Q3 2020: $1.74 (loss) per share | Q1 2021: $0.34 per share | Q2 2021: $0.02 per share | Q3 2021: $0.34 (loss) per share | Q1 2022: $0.51 (loss) per share | Q2 2022: $0.38 (loss) per share | Q3 2022: $0.10 (loss) per share | Q1 2023: $0.43 (loss) per share | Q2 2023: $0.34 (loss) per share | Q3 2023: $0.40 (loss) per share | Q1 2024: $0.75 (loss) per share | Q2 2024: $0.48 (loss) per share | Q3 2024: $0.37 (loss) per share | Q1 2025: $0.40 (loss) per share | Q2 2025: $0.44 (loss) per share | Q3 2025: $0.53 (loss) per share.
- Over the full 7 years of available data (2019 to 2025), Atea Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 39.6%.
- Historical annual values: Fiscal year 2025: $1.94 (loss) per share | Fiscal year 2024: $2.00 (loss) per share | Fiscal year 2023: $1.63 (loss) per share | Fiscal year 2022: $1.39 (loss) per share | Fiscal year 2021: $1.37 per share | Fiscal year 2020: $0.51 (loss) per share | Fiscal year 2019: $1.39 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: